ImageneBio, Inc. share price logo

ImageneBio, Inc.

NASDAQ: IMA

Small Cap

$5.70

+0.09

(+1.60%)

as on

ImageneBio, Inc. Stock Performance

as on May 13, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $5.53
    $5.76
    downward going graph

    2.98%

    Downside

    1.05%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.94
    $18.00
    downward going graph

    30.88%

    Downside

    215.79%

    Upside

    downward going graph

ImageneBio, Inc. share price movements today

Previous Close
$5.61
Open
$5.53
Volume
99.9K
Day's Low - High
$5.53 - $5.76
52 Week Low - High
$3.94 - $18.00

ImageneBio, Inc. Historical Returns

1 Month Return
+ 14.45 %
3 Month Return
-18.1 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

ImageneBio, Inc. Stock Fundamentals & Key Indicators

Check ImageneBio, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$59.7M

EPS (TTM)

-3.965

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-86.16%

ImageneBio, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ImageneBio, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
ImageneBio, Inc. image
ImageneBio, Inc.
NA$59.7MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.4B113.59%74.1312.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.2BNA70.468.94%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$109.1B104.61%25.5135.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$74.9B40.55%17.4529.65%

Indian Investors' Interest in ImageneBio, Inc. Stock

Search interest for ImageneBio, Inc. Stock has increased by 400% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:400% versus previous 30 day period

ImageneBio, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Sep 2024
Dec 2024
Sep 2025
Dec 2025
Total Revenue
0
3
-
-
-
Gross Profit
0
-6
-4
-
0
Operating Income
-21
-12
-12
-26
-8
EBITDA
-21
-11
-12
-24
-7
Interest Expense
1
-
-
0
-
Depreciation
-
-
0
-
0
Income Before Tax
-19
-10
-9
-24
-7
Income Tax Expense
0
0
0
0
0
Net Income
-19
-10
-9
-24
-6
Net Profit Margin
-2957.36%
-292.40%
0.00%
0.00%
0.00%

ImageneBio, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
13
9
30
15
9
3
0
Gross Profit
-37
-11
-35
-16
-48
8
3
0
Operating Income
-40
-18
-44
-34
-70
-75
-37
-48
EBITDA
-40
-18
-44
-33
-70
-74
-35
-47
Interest Expense
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
3
1
1
Income Before Tax
-40
-16
-44
-34
-68
-68
-36
-45
Income Tax Expense
-
0
-
0
-2
0
0
0
Net Income
-40
-16
-44
-34
-68
-68
-36
-45
Net Profit Margin
-4127.78%
-122.28%
-481.36%
-110.10%
-440.29%
-744.17%
-1044.80%
-5668.63%

ImageneBio, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-16
-13
-10
-9
-8
-2
-24
-6
-10
Operating Cash Flow
-18
-12
-8
-6
-10
-3
-26
-7
-14
Investing Cash Flow
-48
3
9
0
7
24
-37
-1
0
Financing Cash Flow
-
-
-
6
-
-
135
-
-3
Change in Cash
-67
-8
0
-5
-2
21
44
-8
-18

ImageneBio, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-16
-44
-34
-68
-68
-49
-52
Operating Cash Flow
47
-37
-60
-74
-79
-46
-47
Investing Cash Flow
0
2
-1
-99
64
-34
-5
Financing Cash Flow
16
116
131
1
75
6
135
Change in Cash
63
81
69
-172
59
-80
82

Insights on ImageneBio, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, IMA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, IMA stock has moved up by 383.6%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 659.0K → 3.5M (in $), with an average increase of 81.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 30.4% return, outperforming this stock by 50.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -6.90M → -10.61M (in $), with an average decrease of 53.7% per quarter

About ImageneBio, Inc.

ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.
OrganisationImageneBio, Inc.
Headquarters12526 High Bluff Drive, San Diego, CA, United States, 92130
IndustryBiotechnology
CEODr. Kristin Yarema Ph.D.
E-voting on sharesClick here to vote

Key Management of ImageneBio, Inc.

Name

Title

Mr. Bob Lally

Senior VP of Finance & Operations and Principal Accounting Officer

Dr. Kurinji Pandiyan Ph.D.

Chief Strategy & Operations Officer

Ms. Renuka Sivendran Ph.D.

Chief Technical Officer

Dr. Benjamin Porter-Brown M.D.

Chief Medical Officer

Dr. Kristin Yarema Ph.D.

CEO, Director & Interim Principal Financial Officer

FAQs

What is ImageneBio, Inc. share price today?

ImageneBio, Inc. share price today is $5.7 as on at the close of the market. ImageneBio, Inc. share today touched a day high of $5.76 and a low of $5.53.

What is the 52 week high and 52 week low for ImageneBio, Inc. share?

ImageneBio, Inc. share touched a 52 week high of $18 on and a 52 week low of $3.94 on . ImageneBio, Inc. stock price today i.e. is closed at $5.7,which is 68.33% down from its 52 week high and 44.67% up from its 52 week low.

What is ImageneBio, Inc.'s market capitalisation today?

ImageneBio, Inc. market capitalisation is $0.00T as on .

How to invest in ImageneBio, Inc. Stock (IMA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ImageneBio, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ImageneBio, Inc. Shares that will get you 0.2632 shares as per ImageneBio, Inc. share price of $5.7 per share as on May 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy ImageneBio, Inc. Stock (IMA) from India?

Indian investors can start investing in ImageneBio, Inc. (IMA) shares with as little as ₹95.618 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in ImageneBio, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on ImageneBio, Inc. share’s latest price of $5.7 as on May 13, 2026 at 1:29 am IST, you will get 1.7544 shares of ImageneBio, Inc.. Learn more about fractional shares .